Skin lesion claims get denied more often than most coders expect and the reason usually traces back to one problem: the diagnosis code doesn’t match what the pathology report actually says. A biller who understands skin lesion ICD-10 selection at the level of laterality, morphology and site can catch these mismatches before a claim ever leaves the office. This guide walks through the code families that matter, the documentation that supports them and the pairing rules that keep reimbursement moving.
What counts as a skin lesion in ICD-10 coding
“Skin lesion” is not itself a diagnostic term in ICD-10-CM. It’s a catchall phrase clinicians use in conversation, but coders have to translate it into something specific: a mole, a cyst, a wart, a carcinoma, an unspecified growth. The code chosen depends entirely on what the documentation supports, not on the word “lesion” appearing in the chart.
That distinction matters because payers reject unspecified codes when the record contains enough detail to support something more precise. If a dermatologist writes “excised skin lesion” without further description and the pathology report comes back identifying a dysplastic nevus, the coder is expected to use the pathology finding, not the vague chart note. Coding to the highest level of specificity supported by the documentation is a standard the AAPC has reinforced repeatedly in its skin lesion coding guidance and Medicare contractors apply it during audits.
Common ICD-10 code categories for skin lesions
Skin lesions split across several chapters of ICD-10-CM depending on whether the growth is benign, malignant, or of undetermined behavior. Getting the chapter right is the first decision point and it drives everything downstream.
Benign skin lesions (D22-D23 range)
Two code families cover the bulk of benign skin growths and they are frequently confused with each other.
D22 (Melanocytic nevi) applies to moles and pigmented growths, including atypical nevus, blue nevus and nevus not otherwise specified. This is where the vast majority of “mole removal” encounters land.
D23 (Other benign neoplasms of skin) covers benign growths arising from hair follicles, sebaceous glands and sweat glands. It explicitly excludes melanocytic lesions and D22 explicitly excludes D23-type growths. The split traces back to a 2015 crosswalk update that divided the old ICD-9 code 216 into these two separate families, according to AAPC’s coding alert archive on the transition.
Both D22 and D23 require a fourth digit for anatomic site and, for several sites, a fifth digit indicating laterality. A benign nevus removed from the left upper eyelid is coded D22.121, not the generic D22.1. Documentation that omits laterality forces the coder into an unspecified fifth digit, which some payers flag during review because the anatomy of an eyelid or a limb makes “unspecified side” look like incomplete charting rather than genuine clinical ambiguity.
One frequent source of confusion: congenital, non-neoplastic marks such as port-wine stains and strawberry nevi are not coded to D22 at all. Those go to Q82.5 (congenital non-neoplastic nevus), a code from the congenital malformations chapter rather than the neoplasm chapter. If a pigmented mole is present at birth but is melanocytic in nature, however, it still belongs in D22, because Q82.5 carries a type 2 excludes note for melanocytic nevi specifically.
Malignant skin lesions and neoplasms (C43-C44 range)
Malignant melanoma is coded under C43, broken down by anatomic site with the same laterality conventions found in the benign families. Other malignant skin neoplasms, including basal cell carcinoma and squamous cell carcinoma, fall under C44. Merkel cell carcinoma has its own dedicated category, C4A, separate from the general C44 family because CMS and the WHO classify it as a distinct clinical entity rather than a subtype of C44.
Carcinoma in situ of the skin sits in D04, a category that often gets miscoded as either C44 (invasive malignancy) or D23 (benign) when pathology reports use ambiguous language. The distinction matters for reimbursement because payers apply different medical necessity criteria to in situ versus invasive disease and an incorrect chapter assignment can trigger a downcode or an outright denial during claims review.
When a malignant lesion spans two adjoining anatomic sites, ICD-10-CM guidelines direct coders to the “.8” overlapping lesion subcategory rather than picking one site arbitrarily, unless the combination already has its own specific index entry. Coders working oncology-adjacent dermatology claims see this rule come up more than the code books suggest, particularly with lesions that straddle the trunk and an extremity.
Unspecified and “other” lesion codes
L98.9 (disorder of the skin and subcutaneous tissue, unspecified) is the code most billing staff reach for when documentation is thin, but it should be treated as a last resort rather than a default. Unspecified codes are acceptable under ICD-10-CM guidelines when the clinical picture genuinely doesn’t support a more specific diagnosis, not when a coder simply didn’t chase down the pathology report.
R23.8 (other skin changes) is a separate, narrower code intended for symptom-level findings rather than confirmed neoplasms and CMS guidance specifically states it should not be used as a principal diagnosis once a definitive diagnosis has been established. Billers sometimes default to R23.8 for a “skin lesion, unspecified” encounter when L98.9 would be the more accurate choice and the two are not interchangeable.
Frequently used skin lesion ICD-10 codes
L98.9 and general dermatologic lesion codes
L98.9 belongs to the “other disorders of skin and subcutaneous tissue” category and functions as a genuine placeholder rather than a specific diagnosis. It’s appropriate for a first encounter where a lesion is noted but not yet biopsied, or where imaging and pathology are still pending. Once pathology results come back, the claim should be updated to reflect the confirmed finding rather than left on L98.9, particularly for excision or biopsy claims where the CPT code already implies a specific tissue diagnosis.
Codes for lesions by body site
Both the benign and malignant lesion families organize their fourth and fifth digits around anatomic site: face, scalp, neck, trunk, upper limb, lower limb and so on, with laterality digits layered on top for paired structures. This structure means that two lesions of identical size and morphology can carry different codes purely because of where they sit on the body. A biller reconciling a claim against an operative note needs to confirm site and side match exactly between the CPT procedure code and the ICD-10 diagnosis, because a mismatch between the two is one of the more common reasons dermatology claims bounce back from clearinghouses before they even reach the payer.
Documentation requirements for accurate lesion coding
Accurate skin lesion coding depends on the provider’s note containing four elements: the anatomic site, laterality where applicable, the morphologic type of lesion (nevus, cyst, keratosis, carcinoma) and, for excisions, the size of the lesion along with the margins taken. Missing any one of these forces the coder toward a less specific code than the encounter actually supports, which increases denial risk.
Pathology reports carry particular weight here. A provider’s pre-operative impression of “benign appearing lesion” is not sufficient once the specimen has been read by pathology. Coding staff should hold excision and biopsy claims until the pathology report is available whenever the CPT code range depends on benign versus malignant status, since billing before the report returns risks coding to the wrong chapter entirely. This is a standard many billing services enforce as a hard rule rather than a suggestion, precisely because 11400-series and 11600-series codes cannot be distinguished without it.
Congenital and vascular birthmarks require particular care in documentation because they cross into an entirely different ICD-10-CM chapter than acquired growths. A chart note that says “birthmark” without specifying whether it is melanocytic or a vascular malformation leaves the coder guessing between D22 and Q82.5, two codes with very different clinical implications.
Common coding errors and denial triggers with skin lesion claims
Several patterns show up repeatedly in dermatology and primary care claims involving skin lesions:
- Coding before pathology returns. Submitting an excision claim with a placeholder benign or malignant code before the pathology report confirms the diagnosis, then failing to correct it if the report contradicts the initial impression.
- Mismatched laterality. The operative note says “left forearm,” but the ICD-10 code submitted carries the “right” or “unspecified” fifth digit.
- Defaulting to unspecified codes. Using L98.9 or R23.8 when the chart actually supports a specific D22, D23, C43, or C44 code, often because the coder didn’t cross-reference the pathology report against the encounter note.
- CPT-ICD-10 mismatch. Billing a malignant excision code (11600-11646) against a benign diagnosis code, or vice versa. Payers run automated edits specifically looking for this inconsistency and it is one of the more frequently cited reasons for dermatology claim denials according to industry billing guidance.
- Confusing congenital nevi with acquired melanocytic nevi. Coding a congenital, non-neoplastic birthmark to D22 instead of Q82.5, or the reverse when the birthmark is actually melanocytic.
Reviewing internal denial management data across specialty claims tends to surface these exact patterns, since diagnosis-to-procedure mismatches are among the more preventable denial categories once a practice knows what to check for.
Skin lesion ICD-10 pairing with CPT codes for excisions and biopsies
The ICD-10 diagnosis code has to align logically with whichever CPT procedure code the provider bills and skin lesion claims have a fairly defined set of procedure codes to work with.
Biopsy codes are selected by technique rather than diagnosis. Tangential (shave) biopsy uses 11102 for the first lesion and the add-on code 11103 for each additional lesion biopsied the same way. Punch biopsy uses 11104 with add-on code 11105. Incisional biopsy uses 11106 with add-on code 11107. Only one primary biopsy code gets billed per encounter; additional lesions sampled with the same technique are reported through the corresponding add-on code, not by repeating the primary code.
Excision codes work differently, since they depend on the pathology outcome rather than technique alone. Benign lesion excisions fall in the 11400-11446 range and malignant lesion excisions fall in 11600-11646. Both ranges are further divided by anatomic location (trunk and extremities carry one set of codes; face, ears, eyelids, nose and lips carry a higher-valued set) and by the excised diameter, which includes the surgical margin, not just the visible lesion itself. Because the benign-versus-malignant distinction determines which entire code range applies, billing staff who submit before pathology confirmation run a real risk of having to rebill the claim once results return.
Destruction codes (17000-17286) apply when a lesion is removed by cryosurgery, electrosurgery, laser, or curettage rather than excised as a specimen. These are billed by lesion count rather than by size, with separate code families for premalignant, benign and malignant destructions. A biller should confirm which method the operative note actually describes, since destruction and excision are documented and coded through entirely different logic even when the end result, in plain language, is “the lesion is gone.”
How specificity affects reimbursement
Unspecified codes are not automatically denied, but they draw more scrutiny and some payers apply medical policy edits that require a specific diagnosis before certain procedures are covered. A shave biopsy billed against L98.9 may process without issue for a first encounter, but a benign excision billed against an unspecified code when the pathology report is already on file in the chart gives a reviewer an easy reason to request records or deny the claim for insufficient specificity.
Laterality errors carry a similar cost. Many clearinghouse edits check that CPT laterality modifiers, when used, agree with the ICD-10 fifth digit. A claim where the CPT code and modifier say “right” while the diagnosis code’s fifth digit says “left” is likely to reject before it reaches the payer’s adjudication system at all, adding a full billing cycle of delay for what amounts to a data entry mismatch.
Practices that route their dermatology and skin lesion claims through a structured coding audit process tend to catch these specificity and laterality gaps before submission rather than after a denial arrives, which is a meaningfully cheaper place to catch them.
Best practices for billers and coders working with lesion diagnoses
A few habits separate accurate skin lesion coding from claims that bounce back for correction.
Hold excision claims for pathology whenever the CPT code range depends on benign versus malignant status. Confirm anatomic site and laterality against the operative note line by line rather than relying on the chief complaint alone. Treat L98.9 and R23.8 as placeholders that get replaced once a specific diagnosis is available, not as permanent answers. Cross-check that the CPT procedure code and the ICD-10 diagnosis code tell a consistent clinical story: a malignant excision code paired with a benign diagnosis code, or a biopsy code paired with a destruction-only description, both signal a documentation gap that needs resolution before the claim goes out.
For practices handling a high volume of dermatology or primary care skin lesion visits, building these checks into a practice management workflow rather than relying on individual coder memory tends to produce more consistent first-pass claim acceptance, since the rules involved (fourth-digit site, fifth-digit laterality, pathology confirmation, CPT alignment) are mechanical enough to standardize into a checklist.
Skin lesion coding rewards patience more than speed. The codes themselves aren’t complicated once the anatomy and laterality conventions are clear, but the discipline of waiting for pathology, matching CPT to ICD-10 and resisting the pull toward unspecified codes is what actually keeps these claims out of the denial queue.
Make An Appintment With Us
